重症哮喘持续性气流受限相关转录组基因特征
本研究基于U-BIOPRED队列的重症哮喘患者,比较伴持续性气流受限(PAL)与不伴PAL者的基因表达,采用基因集变异分析(GSVA)检测痰液、鼻刷、支气管刷和活检样本中差异富集的预设基因特征,发现PAL与吸入激素反应、嗜酸性粒细胞、IL-13、IFN-α、特定CD4+ T细胞及气道重塑相关的基因网络有关。
要点
- 重症哮喘PAL患者存在可区分的潜在基因网络。
- 差异富集基因特征涉及激素反应、炎症通路和气道重塑。
- 这些发现为重症哮喘PAL的治疗提供了潜在靶点。
核心结论
- 重症哮喘中的持续性气流受限具有可区分的潜在基因网络,与治疗、炎症通路和气道重塑相关。
研究设计与样本
- 基于U-BIOPRED队列,比较伴PAL与不伴PAL的重症哮喘患者。
- 对痰液细胞、鼻刷、支气管刷和支气管活检的总RNA进行基因表达评估。
- 应用GSVA识别基于现有气道疾病基因表达数据的差异富集预设基因特征。
主要发现
- 在鼻刷(n=1)、痰液(n=9)、支气管刷(n=1)和支气管活检(n=4)中识别出差异富集的基因特征。
- 差异富集基因特征与吸入激素反应、嗜酸性粒细胞、白细胞介素-13、干扰素-α、特定CD4+ T细胞和气道重塑相关。
关键数值与推荐
- PAL定义为支气管舒张后第1秒用力呼气容积/用力肺活量比值低于正常下限。
临床怎么用
- 这些发现提示针对重症哮喘PAL的治疗靶点,可能涉及激素反应、2型炎症和气道重塑通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A proportion of severe asthma patients suffers from persistent airflow limitation (PAL), often associated with more symptoms and exacerbations. Little is known about the underlying mechanisms. Here, our aim was to discover unexplored potential mechanisms using Gene Set Variation Analysis (GSVA), a sensitive technique that can detect underlying pathways in heterogeneous samples.Severe asthma patients from the U-BIOPRED cohort with PAL (post-bronchodilator forced expiratory volume in 1 s/forced vital capacity ratio below the lower limit of normal) were compared with those without PAL. Gene expression was assessed on the total RNA of sputum cells, nasal brushings, and endobronchial brushings and biopsies. GSVA was applied to identify differentially enriched predefined gene signatures based on all available gene expression publications and data on airways disease.Differentially enriched gene signatures were identified in nasal brushings (n=1), sputum (n=9), bronchial brushings (n=1) and bronchial biopsies (n=4) that were associated with response to inhaled steroids, eosinophils, interleukin-13, interferon-α, specific CD4+ T-cells and airway remodelling.PAL in severe asthma has distinguishable underlying gene networks that are associated with treatment, inflammatory pathways and airway remodelling. These findings point towards targets for the therapy of PAL in severe asthma.
引用
- Hekking PP, Loza MJ, Pavlidis S, et al. Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma. Eur Respir J. 2017. PMID: 28954779. doi:10.1183/13993003.02298-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。